Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Pregnancy”

1,288 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,288 results

Not applicableLooking for participantsNCT04751435
What this trial is testing

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Who this might be right for
Educational Materials for Genetic TestingBreast CancerOvarian Cancer+3 more
Memorial Sloan Kettering Cancer Center 445
Not applicableNot Yet RecruitingNCT07236359
What this trial is testing

Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction

Who this might be right for
Breast ReconstructionBreast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)+1 more
Beaumont Hospital 108
Early research (Phase 1)UnknownNCT05498597
What this trial is testing

AMT-151 in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more
Multitude Therapeutics Inc. 30
Early research (Phase 1)Study completedNCT03289962
What this trial is testing

Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
MelanomaNon-Small Cell Lung CancerBladder Cancer+5 more
Genentech, Inc. 272
Early research (Phase 1)Study completedNCT02437539
What this trial is testing

Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

Who this might be right for
Breast CancerProstate CancerUrinary Bladder Cancer
Rigshospitalet, Denmark 10
Early research (Phase 1)Looking for participantsNCT04778839
What this trial is testing

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
First Affiliated Hospital of Zhejiang University 98
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Not applicableActive Not RecruitingNCT04197856
What this trial is testing

Direct Information to At-risk Relatives

Who this might be right for
Familial Breast CancerFamilial Colorectal CancerHereditary Breast and Ovarian Cancer Syndrome+2 more
Umeå University 490
Very early researchStudy completedNCT01697345
What this trial is testing

Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy

Who this might be right for
Breast CancerVaginal DrynessDyspareunia+1 more
Creighton University 12
Large-scale testing (Phase 3)Ended earlyNCT00429403
What this trial is testing

Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableStudy completedNCT02122588
What this trial is testing

OVArian Cancer Non-Interventional Study - OVATAR

Who this might be right for
Ovarian, Peritoneal, Fallopian Tube Cancer, BRCAm+ in Russia
AstraZeneca 503
Early research (Phase 1)Study completedNCT02014337
What this trial is testing

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

Who this might be right for
Breast CancerOvarian Epithelial Cancer RecurrentSarcoma+4 more
Corcept Therapeutics 37
Large-scale testing (Phase 3)WithdrawnNCT01724242
What this trial is testing

Vaginal DHEA for Women After Breast Cancer

Who this might be right for
Vaginal DrynessBreast CancerUrinary Incontinence+2 more
Hadassah Medical Organization
Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Not applicableStudy completedNCT01621295
What this trial is testing

Assessing the Patient Experience in Cancer Care

Who this might be right for
Brain NeoplasmBreast NeoplasmEndocrine Gland Neoplasm+7 more
Mayo Clinic 408
Early research (Phase 1)Ended earlyNCT05067972
What this trial is testing

PF-07260437 in Advanced or Metastatic Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsBreast Neoplasms
Pfizer 30
Testing effectiveness (Phase 2)Ended earlyNCT05716295
What this trial is testing

A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Medikine, Inc. 26
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Ended earlyNCT06065059
What this trial is testing

Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors

Who this might be right for
Breast CancerOvarian CancerPancreas Cancer+5 more
Tango Therapeutics, Inc. 7
Load More Results